MOLECULAR PARTNERS AG Equity
MOLECULAR PARTNERS AG (MOLN) had Equity of CHF 80.33 million as of 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Notes
ifrs-full:Equity · last filed 2026-03-12
- 2025-12-31: Equity 80.33M CHF.
- 2025-06-30: Equity 106.66M CHF.
- 2024-12-31: Equity 141.64M CHF.
- 2024-06-30: Equity 155.57M CHF.
| Period end | Equity |
|---|---|
| 2025-12-31 | 80.33M CHF 20-F · filed 2026-03-12 |
| 2025-06-30 | 106.66M CHF 6-K · filed 2025-08-25 |
| 2024-12-31 | 141.64M CHF 20-F · filed 2026-03-12 |
| 2024-06-30 | 155.57M CHF 6-K · filed 2025-08-25 |
| 2023-12-31 | 176.43M CHF 20-F · filed 2026-03-12 |
| 2023-06-30 | 205.98M CHF 6-K · filed 2024-08-26 |
| 2022-12-31 | 235.17M CHF 20-F · filed 2026-03-12 |
| 2022-06-30 | 265.87M CHF 6-K · filed 2023-08-24 |
| 2021-12-31 | 107.29M CHF 20-F · filed 2025-03-06 |
| 2021-06-30 | 134.64M CHF 6-K/A · filed 2022-08-31 |
| 2020-12-31 | 107.22M CHF 20-F · filed 2024-03-14 |
| 2019-12-31 | 54.14M CHF 20-F · filed 2023-03-09 |
| 2018-12-31 | 91.70M CHF 20-F · filed 2022-03-15 |